Skip to content

Bills · 2019-2020 Regular Session

SB 927

Died at session end Official bill text Atom feed

Relating to: regulating the sale of certain drugs and medical supplies below cost.

Disease Drugs Medical service Trade practice

  1. Introduced, stopped here
  2. Passes Senate, not reached
  3. Passes Assembly, not reached
  4. Governor signs, not reached
  5. Law, not reached

Unfamiliar terms? Glossary

What this bill does

Plain-language analysis by the nonpartisan Legislative Reference Bureau

This bill exempts pharmaceutical, treatment, and other medical supplies used

for treating COVID-19 from the Unfair Sales Act, also called the minimum markup

law, during the public health emergency declared on March 12, 2020, by executive

order 72.

Under current law, the Unfair Sales Act prohibits retailers and wholesalers

from selling merchandise, including pharmaceutical, treatment, and other medical

supplies, for less than the cost of the merchandise to the retailer or wholesaler.

Sponsors

Introduced by: Carpenter (D) , Craig (R) , Jacque (R) , Kooyenga (R) , Stroebel (R)

11 cosponsors

Allen (R) , Brandtjen (R) , Brooks (R) , Dittrich (R) , Gundrum (R) , Murphy (R) , Ott (R) , Ramthun (R) , Rohrkaste (R) , Schraa (R) , Wichgers (R)

Full history

  1. Mar 26, 2020 · Senate

    Introduced by Senators Kooyenga, Carpenter, Craig, Stroebel and Jacque; cosponsored by Representatives Ott, Ramthun, Allen, Brandtjen, Brooks, Dittrich, Murphy, Rohrkaste, Schraa, Wichgers and Gundrum

  2. Mar 26, 2020 · Senate

    Read first time and referred to Committee on Economic Development, Commerce and Trade

  3. Apr 1, 2020 · Senate

    Failed to pass pursuant to Senate Joint Resolution 1